Vascular Graft Market Analysis & Forecast to 2024-2034

The global vascular graft market size was estimated to be USD 2.53 billion in 2023 and is expected to reach at USD 5.68 billion by 2034 with a CAGR of 7.63% during the forecast period 2024-2034. Surge in number of dialysis procedures, growing prevalence of chronic kidney disease (CKD), cardiovascular diseases, diabetes, & end-stage renal disease, increasing healthcare expenditure, rising demand for technologically advanced products, surge in demand for minimally invasive procedures, growing focus on development of next-generation tissue-engineered vascular grafts to treat various vasculopathies, increasing adoption of MIDCAB procedure, rising advancement in surgical procedures using coronary artery stent-grafts, and surge in introduction of innovative surgical graft products are some of the key factors boosting the market growth.

Surge in regulatory approval of innovative graft products is predicted to boost the market growth during the forecast period. Vascular grafts are mainly used for haemodialysis vascular access and endovascular aneurysm & thoracic aneurysm repair which anticipated to rise the demand for novel graft products. For instance, in May 2023, Terumo Aortic has received approval from the US Food and Drug Administration (FDA) for the use of the RelayPro Thoracic Stent-Graft device in the United States to treat dissection and transection.

By product, endovascular stent-grafts was the highest revenue-grossing segment in the global vascular graft market in 2023 owing to growing adoption of endovascular stent-grafts to treat aneurysms including thoracic aortic aneurysms, rising demand for the treatment of abdominal aortic aneurysm (AAA), increasing technological development of endovascular application, and surge in approvals by regulatory bodies. For instance, in May 2023, Terumo Aortic has received FDA approval for the RelayPro thoracic stent graft, allowing its use in the treatment of dissection and transection. Additionally, peripheral vascular grafts is predicted to grow at fastest CAGR during the forecast period owing to increasing prevalence of renal failure & hardening of arteries, rising focus on development of technologically advanced products for the treatment of peripheral artery disease

By application, cardiac aneurysm was the highest revenue-grossing segment in the global vascular graft market in 2023 owing to increasing prevalence of high blood pressure, growing cholesterol levels, rising adoption of sedentary lifestyle, surge in geriatric population, increasing number of congenital heart surgeries carried out using advanced tissue-engineered grafts, and growing adoption of minimally invasive vascular implants. Additionally, vascular occlusion is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patients with vascular occlusion disease, increasing demand for the treatment of vascular occlusion using synthetic grafts such as Polytetrafluoroethylene (PTFE), and rising approvals of novel products by regulatory bodies. For instance, in January 2023, Endovastec has been granted registration approval by the Ministry of Food and Drug Safety of Korea (MFDS) for their Minos® Abdominal Aortic Stent-Graft and Delivery System (Minos® Stent Graft System), which they developed independently.

By raw material, polytetrafluoroethylene vascular grafts was the highest revenue-grossing segment in the global vascular graft market in 2023 owing to its advantages, such as its high-pressure tolerance and great patency rates, rising usage for peripheral bypass procedures & extra-anatomical surgeries, growing technological modifications such as PTFE treated with argon plasma for the development of novel products. Additionally, polyester vascular graft is predicted to grow at fastest CAGR during the forecast period owing to the raw resources being accessible as well as benefits such as toughness & durability, surge in number of patients with vascular heart disease, growing demand for functional polyester vascular grafts with small diameters, and increasing investment for the development of advanced products. For instance, in May 2022, UC Davis has been granted a CIRM grant of $3 million to develop an intelligent vascular graft for patients with renal conditions. This device utilizes a unique chemical to guide the body's stem cells, aiming to decrease the occurrence of artificial vascular graft failures, a common issue among patients undergoing hemodialysis for renal disease.

North America region is anticipated for the highest revenue share during the forecast period owing to the growing awareness regarding health & availability of health care, increasing reimbursement policies, rising adoption of advanced technological procedures, surge in use of biometric tools to accurately diagnose the disease, growing technological developments & discoveries of tissue-engineered products, increasing research & development activities for the development of grafts using advanced biomaterial, and rising regulatory approvals. For instance, in August 2022, W. L. Gore & Associates, Inc., a global materials science company dedicated to innovation across various industries, has acquired InnAVasc Medical, Inc., a privately held healthcare technology company. InnAVasc Medical, Inc. is focused on improving the care provided to individuals with end-stage renal disease undergoing dialysis treatment with graft circuits. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patients with cardiovascular diseases, growing technological advancements, rising launch of advanced products, and increasing approvals by regulatory bodies. For instance, in December 2021, Shanghai MicroPort Endovascular Med Tech (Group) Co., Ltd. has obtained registration approval from the Indian Central Drugs Standard Control Organization (CDSCO) for its Hercules Low Profile Thoracic Stent Graft and Delivery System (Hercules-LP). This marks the inaugural approval for marketing of an Endovastec product in India.

Segmentation: Vascular Graft Market Report 2022 - 2033

Vascular Graft Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)

• Vascular Grafts for Aorta Disease
• Hemodialysis Access Grafts
• Endovascular Stent Grafts
• Peripheral Vascular Grafts
• Coronary Artery By-Pass Grafts

Vascular Graft Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

• Kidney Failure
• Vascular Occlusion
• Cardiac Aneurysm
• Coronary Artery Disease

Vascular Graft Market Analysis & Forecast by Raw Material 2023 - 2034 (Revenue USD Bn)

• Polytetrafluoroethylene Vascular Grafts
• Polyester Vascular Grafts
• Biological Material Based Vascular Grafts
• Polyurethane Vascular Grafts

Vascular Graft Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of LATAM
• Middle East & Africa
• South Africa
• GCC
• Rest of MEA